FDA Adviser Dr. Caleb Alexander of John’s Hopkins talks about Aducanumab/Aduhelm: a groundbreaking Alzheimer’s treatment sent to market in one of the most controversial FDA approvals ever.
Listen to this podcast by clicking the link below, or the arrow in the player below. Or listen on iTunes or your favorite podcast distributor under "The Sharyl Attkisson Podcast" and "Full Measure After Hours." Subscribe, Share, Review and Follow my podcasts on Twitter @TheSharylPodcast @FullMeasureAH
Visit The Sharyl Attkisson Store
Cool Products for Free Thinkers
Support Independent Journalism